| |
| | In Vivo Metabolic Activity of CYP2C19 and CYP3A in Relation to CYP2C19 Genetic Polymorphism in Chronic Liver Disease -- ... |
 | | From the Department of Laboratory Medicine, Daisan Hospital, Jikei University School of Medicine, Tokyo, Japan (Dr Ohnishi, Dr Akizuki), the Division of Gastroenterology and Hepatology, Daisan Hospital, Jikei University School of Medicine, Tokyo, Japan (Dr Murakami, Dr Mochizuki, Dr Takagi), and the Department of Pharmacotherapy, Meiji Pharmaceutical University, Tokyo, Japan (Dr Echizen). |
 | | To study whether chronic liver disease (CLD) and genetic polymorphism |
 | | Address for reprints: Akihiro Ohnishi, MD, PhD, Department of Laboratory Medicine, Daisan Hospital, Jikei University School of Medicine, 4-11-1 Izumihonchyo, Komae, Tokyo 201-8601. |
| jcp.sagepub.com /cgi/content/abstract/45/11/1221 (396 words) |
|